Comorbidity of schizophrenia and diabetes mellitus at the present stage of development of an interdisciplinary approach to treatment and diagnosis

Author:

Cherepakhin D. I.ORCID, ,Aronov P. V.ORCID, ,

Abstract

The article presents an overview of the current problem of comorbidity of schizophrenia and type 2 diabetes mellitus, the diseases that considerably limit the quality of life of patients and cause significant difficulties in patient management. We seek to clarify the current understanding of the factors contributing to the coexistence of these diseases, highlighting the potential role of genetic, epigenetic, and environmental factors in this regard. Particular attention is paid to the effect of antipsychotic drugs on glucose metabolism and the development of insulin resistance, which may contribute to the development of type 2 diabetes in patients with schizophrenia. Data from the most relevant studies on this issue are presented, and possible strategies for managing patients with these conditions are discussed. The purpose of this article is not only to collect and systematize the existing information on the comorbidity of schizophrenia and type 2 diabetes, but also to stimulate further research in this area to develop effective approaches to the diagnosis, treatment, and management of patients with these comorbid pathologies.

Publisher

PANORAMA Publishing House

Subject

General Medicine

Reference7 articles.

1. 1. Yang, W.-W., Zhang, J.-W., Chen, L.-L., Fu, J.-Y., Zhu, J.-Y., & Wang, Y.-B. (2019). People with schizophrenia have a 2-5 times higher risk of developing type 2 diabetes than the general population. PubMed. Available at: https://pubmed.ncbi.nlm.nih.gov/31555784/

2. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders;Cohen;PubMed Available at https//pubmed,2006

3. 3. Varnakova T.V., Artemieva M. S., Shinko S. Iu. Analiz kachestva zhizni patsientov s sochetannym techeniem shizofrenii i sakharnogo diabeta [Analysis of the quality of life of patients with combined course of schizophrenia and diabetes mellitus]. / Tekhnologii zhivykh sistem [Technologies of Living Systems]. Vol. 9, No. 7, 2012, p. 33-36. issn 2070-0997 Available at http://www.radiotec.ru. (In Russ.)

4. 4. Vestri, H. S., Maianu, L., Moellering, D. R., & Garvey, W. T. (2006). Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. PubMed. Available at: https://pubmed.ncbi.nlm.nih.gov/16823387/

5. 5. Shinozaki, K. (2015). An Overview of Diabetes Management in Schizophrenia Patients: Office Based Strategies for Primary Care Practitioners and Endocrinologists. Hindawi. Available at: https://www.hindawi.com/journals/ije/2015/969182/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3